Related Experiment Videos
Mechanisms and selectivity of anthracycline aminoglycosides and other intercalating agents
Abstract:
Many of the antiproliferative actions of daunorubicin and adriamycin are attributable to the results of their interaction with DNA: single and double strand breaks and inhibition of repair and of nucleic acid synthesis. Like other DNA-reactive agents, high cumulative doses produce pharmacological actions and species-specific cytotoxicities in non-proliferating myocardium and nerve cells. Evidence is reviewed suggesting that many, if not all, intercalating agents are membrane-reactive. Thus it seems likely that the selective nature of the responses by various cells and the discrete expressions of cytotoxicity may be determined by binding to specific receptors in membranes of target cells in susceptible organs and species.
Insights
Daunorubicin and adriamycin damage DNA, causing antiproliferative effects. Their selective toxicity may stem from interactions with cell membranes, not just DNA.
Area of Science:
- Pharmacology
- Molecular Biology
- Toxicology
Background:
- Daunorubicin and adriamycin are chemotherapy drugs.
- Their antiproliferative effects are linked to DNA damage.
Purpose of the Study:
- To explore the mechanisms behind the selective toxicity of daunorubicin and adriamycin.
- To investigate the role of cell membranes in drug action.
Main Methods:
- Review of existing evidence on DNA-reactive agents.
- Analysis of intercalating agents and their potential membrane interactions.
Main Results:
- DNA damage (strand breaks, inhibited synthesis/repair) is a key effect.
- High doses cause toxicity in non-proliferating cells (myocardium, nerve).
- Evidence suggests intercalating agents also interact with cell membranes.
Conclusions:
- Selective cytotoxicity may be determined by specific receptor binding in target cell membranes.
- Membrane interactions, in addition to DNA effects, likely contribute to drug selectivity and toxicity.